Upcoming Webinars
-
FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry
In this webinar, Denise Holliday, Expert Witness at Capwell Consulting Group, helps you understand how the transition to QMSR may affect regulatory compliance, product liability exposure, and organizational risk.
Register for FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry Read More about FDA QSR to QMSR: Regulatory, Legal, and Risk Implications for Industry
Past Webinars
-
Don’t Think You’re a Manufacturer? You Might Be an Apparent Manufacturer: A Look at the Apparent Manufacturer Doctrine
This webinar discusses the Apparent Manufacturer Doctrine under which a nonmanufacturing retailer may be held liable as the manufacturer of a defective product. This doctrine has been ascending in...
Read More about Don’t Think You’re a Manufacturer? You Might Be an Apparent Manufacturer: A Look at the Apparent Manufacturer Doctrine -
Life Sciences Claims 2022: Redefining Normalcy
In this year’s annual year-end wrap-up, a panel including Andy Hall and Lauren Hulbert with Medmarc’s claims department, as well as Jennifer Heis, an attorney with Ulmer Berne, will provide a claims...
Read More about Life Sciences Claims 2022: Redefining Normalcy -
EUAs, 510(k)s and De Novos Demystified: Bringing COVID-19 Tests to the US Market
COVID-19 test developers and regulatory bodies rose to the challenge of quickly supplying the public with the tests necessary to determine infection status. However, many of these tests were brought...
Read More about EUAs, 510(k)s and De Novos Demystified: Bringing COVID-19 Tests to the US Market -
Increasing Diversity in Clinical Trials: FDA Guidance and Industry Efforts
This webinar will discuss efforts to increase enrollment in clinical trials of people from underrepresented racial and ethnic populations. We will discuss the latest FDA actions as well as efforts...
Read More about Increasing Diversity in Clinical Trials: FDA Guidance and Industry Efforts